Company / CapEx per Share
Ultragenyx Pharmaceutical Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.06
FY2025
5-year range
$0.06 / $1.67
FY2021-FY2025
Trend
-23.7%
vs FY2024
Sector context
#69 of 192
Health Care
What the data says
At $0.06, Ultragenyx Pharmaceutical Inc.'s capex per share ranks #69 of 192 in the Health Care sector. CapEx per Share has declined for 3 consecutive years, from $1.67 in FY2022 to $0.06 in FY2025.
Based on SEC 10-K filings.
0.06 in FY2025 with a 5-year CAGR of -1.6%.
Declined from $0.63 to $0.06 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -66.2%
- 5-Year CAGR
- -1.6%
- 10-Year CAGR
- -
Sector benchmark
#69 of 192 in Health CareTop 36% of 192This company $0.06 Sector average $3.54
▼
-98.2% below sector average
Key checks
Key Insights
- Ultragenyx Pharmaceutical Inc.'s capex per share has declined for 3 consecutive years.
- In FY2025, capex per share decreased 23.7% year-over-year.
- Ranks #69 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.06 | -23.7% |
| FY2024 | $0.09 | -86.4% |
| FY2023 | $0.63 | -62.6% |
| FY2022 | $1.67 | +350.6% |
| FY2021 | $0.37 | +427.3% |
| FY2020 | $0.07 | +28.3% |
| FY2019 | $0.05 | -40.5% |
| FY2018 | $0.09 | -23.2% |
| FY2017 | $0.12 | +117.4% |
| FY2016 | $0.06 | -59.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026